| Literature DB >> 31534960 |
Daniel Baksa1,2, Kinga Gecse1,2, Sahel Kumar2,3, Zsuzsanna Toth1,2, Zsofia Gal3,4, Xenia Gonda3,5,6, Gabriella Juhasz1,2,3,7.
Abstract
Several studies suggested that migraine attack onset shows a circadian variation; however, there has not been an overview and synthesis of these findings. A PubMed search with keywords "migraine" AND "circadian" resulted in ten studies directly investigating this topic. Results of these studies mostly show that migraine attacks follow a monophasic 24-hour cyclic pattern with an early morning or late night peak while other studies reported an afternoon peak and also a biphasic 24-hour cycle of attacks. The identified studies showed methodological variation including sample size, inclusion of medication use, comorbidities, and night or shift workers which could have contributed to the contradictory results. Several theories emerged explaining the diurnal distribution of migraine attacks suggesting roles for different phenomena including a morning rise in cortisol levels, a possible hypothalamic dysfunction, a circadian variation of migraine triggers, sleep stages, and a potentially different setting of the circadian pacemaker among migraineurs. At the moment, most studies show an early morning or late night peak of migraine attack onset, but a significant amount of studies reveals contradictory results. Further studies should investigate the arising hypotheses to improve our understanding of the complex mechanism behind the circadian variation of migraine attacks that can shed light on new targets for migraine therapy.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31534960 PMCID: PMC6732618 DOI: 10.1155/2019/4616417
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flowchart of study selection strategy performed after PubMed search for studies directly investigating the circadian variation of migraine attack onset.
Details and results of the studies on circadian variation of migraine attack onset.
| Study | Design | Time-span | Sample | Age (years) [ | Female [ | Migraine type (sample size if available) | Medication | Comorbid factors | Night work/shift work | Circadian variation of attack onset (peak) |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
|
| ||||||||||
| Solomon (1992) [ | prospective | 20 weeks | 15 patients (USA) | no data | no data | MO, MA | NSAID or placebo used (beta-blockers excluded) | healthy (except migraine) | no data | 6AM-12AM |
|
| ||||||||||
| Fox & Davis (1998) [ | retrospective | last 3 years | 1698 patients (USA) | from 18 to 60+ | 89% | MO, MA | use of oral contraceptives included | no data | included | 4AM-9AM |
|
| ||||||||||
| Fox (2005) [ | literature data analysis | - | 1698 patients (USA) | from 18 (median: 34) | ~4:1 | MO, MA | excluded w. oral contraceptives | no data | not included | 1AM-6AM |
|
| ||||||||||
| Gori, et al. (2005) [ | retrospective | last 3 months | 100 patients (Italy) | patients (23-50), mean: 38.6; control (23-60), mean: 37.1 | no data | MO | no data | depression and anxiety symptoms; sleep quality | no data | 3AM-7AM |
|
| ||||||||||
| Alstadhaug, et al. (2008) [ | prospective | 12 months | 84 patients (arctic) | mean ~35 | 100% | MO (34), MO+MA (50) | use of oral contraceptives, beta-blockers included | healthy (except migraine); insomnia | included | at 1.40PM |
|
| ||||||||||
| Park, et al. (2018) [ | prospective | 90 days | 82 patients (Korea) | mean 37.4 | 84.1% | MO (81), MA (1) | use of acute & preventive medication allowed | non-migraine type headache | not included | 6AM-12AM |
|
| ||||||||||
|
| ||||||||||
|
| ||||||||||
| Soriani, et al. (2006) [ | prospective | 12 months | 115 patients (pediatric) (Italy) | 5-18 yrs (median: ~10) | 47% [ | MO | excluded if taking prophylactic medication | no data | - | main peak at 4:48PM, secondary peak at 6:35AM |
|
| ||||||||||
| Alstadhaug, et al. (2007) [ | prospective | 12 months | 68 patients (arctic) | mean 35.5 | 100% | MO, MA (insomnia-related (29%) & not related attacks) | excluded if taken beta-blockers | possible chronic insomnia; sleep quality on the night prior to or the night of the attack | not included | insomnia related: peak early in the morning (~8AM) & just after noon/not related: peak just after noon |
|
| ||||||||||
| van Oosterhout, et al. (2018) [ | cross-sectional | - | 2389 patients, 189 controls (Dutch) | mean 45.2 [ | 83.4% [ | MO, MA | use of sleep medication (no data on migraine medication) | depression and anxiety symptoms, lifetime depression; sleep quality | included | peaks: from midnight to 6AM (34.5%) & from 6AM to noon (31.7%) |
|
| ||||||||||
| de Tommaso & Delussi (2018) [ | prospective | 3 months | 786 cases (Italy) | means: MO – 37.4; MO+MA – 34.2; CM – 42.5 [ | ~80% | MO (538), MO+MA (52), CM (196) | exclusion: use of central nervous system-active drugs or preventive treatment for primary headache | healthy (except migraine); depression and anxiety symptoms; sleep features; quality of life | no data | two peaks: at 10AM & at 10PM (but most patients did not report a constant circadian rhythm of their attacks) |
Table 1 shows the results and other important details of the selected studies on circadian variation of migraine attack onset. Abbreviations. CM: chronic migraine; MA: migraine with aura; MO: migraine without aura; NSAID: nonsteroidal anti-inflammatory drug; ∗: adjustment for effect.